Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice
ACS Biomaterials Science & Engineering · 2023
DOI: 10.1021/acsbiomaterials.3c01191 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2023. Verfasst von Shan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China. Hauptthemen laut MEDLINE: Colitis, Cyclosporine, Reactive Oxygen Species, Nanoparticles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Army Medical University.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a frequently occurring disease that seriously influences the patient's quality of life. To decrease adverse effects and improve efficacy of therapeutics, nanomedicines have been widely used to treat IBD. However, how to thoroughly release payloads under an inflammatory microenvironment and synergistic therapy of IBD need to be further investigated. To address this issue, cyclosporine A (CsA)-loaded, folic acid (FA)-modified, pH and reactive oxygen species (ROS) dual-responsive nanoparticles (FA-CsA NPs) were fabricated using pH/ROS-responsive material as carrier. The prepared FA-CsA NPs had spherical shape and uniform size distribution and could smartly release their payloads under acid and/or ROS microenvironment. In vitro experiments demonstrated that FA-CsA NPs can be effectively internalized by activated macrophages, and the internalized NPs could down-regulate the expression of proinflammatory cytokines compared to free drug or nontargeted NPs. In vivo experiments verified that FA-CsA NPs significantly accumulated at inflammatory colon tissues and the accumulated NPs obviously improved the symptoms of colitis in mice without obvious adverse effects. In conclusion, our results provided a candidate for the targeted treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
- Department of Chemistry, College of Basic Medicine, Army Medical University (Third Military Medical University), Chongqing 400038, China.
- Department of Orthopaedics, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China.
ORCID-Profile: Dinglin Zhang
Förderung
- Army Medical University
Zitieren
APA
Li, S., Wu, T., Wu, J., Zhou, J., Yang, H., Chen, L., Chen, W., & Zhang, D. (2023). Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.3c01191
Vancouver
Li S, Wu T, Wu J, Zhou J, Yang H, Chen L, et al. Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice. ACS Biomaterials Science & Engineering. 2023. doi:10.1021/acsbiomaterials.3c01191
BibTeX
@article{Li2023,
author = {Li, Shan and Wu, Tianyu and Wu, Jingfeng and Zhou, Jiangling and Yang, Hong and Chen, Lei and Chen, Wensheng and Zhang, Dinglin},
title = {Cyclosporine A-Encapsulated pH/ROS Dual-Responsive Nanoformulations for the Targeted Treatment of Colitis in Mice},
journal = {ACS Biomaterials Science & Engineering},
year = {2023},
doi = {10.1021/acsbiomaterials.3c01191}
}
EUVIMED